AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

It was the best of biotech times, it was the worst of biotech times: One company soars, another stumbles and a third outlines ...

A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients. Serina Therapeutics, based ...

News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

Company Logo Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...